Search
Menu
Home
HTB
2006
September
HTB
September 2006
Contents
Editorial
Volume 7 Number 9 September 2006
Conference reports
XVI International AIDS Conference, Toronto, Canada. 13-18 August 2006
Enough is enough: South African activists demand: fire Manto
Treatment access: more optimistic results from scale up programmes
Integrase inhibitor MK-0518: early results show greater early potency than efavirenz
Maraviroc results in R5/X4 mixed/dual tropic patients: unexpected safety data shows possible immunolocical effect
Vicriviroc 24-week results in triple-class experienced R5-tropic patients
Etravirine (TMC-125) associated with -1 log viral load reduction at 48-weeks results in treatment experienced patients
Three-class experienced patients experience 1 log viral load reduction using monoclonal antibody TNX-355
New data on darunavir (TMC-114)
Lopinavir/r monotherapy: less potent than triple therapy with higher risk of resistance
Atazanavir/r monotherapy and CNS penetration
Fosamprenavir/r is non-inferior to Kaletra in treatment naive patients
Tenofovir/FTC maintains greater virological response and reduced lipoatrophy compared to AZT/3TC after 96 weeks
Children face a serious service delivery gap: paediatric studies in Toronto
Bioavailability study results for new paediatric tablets for oral suspension, and caution against splitting adult doses
Pharmacokinetic and virological evaluations after stopping NNRTIs in children: a substudy of the PENTA 11 (TICCH) Trial
3TC/abacavir maintains virological superiority over AZT/3TC and AZT/abacavir beyond 5 years in children
French study raises importance of early screening for anal cancer in HIV-positive people
Prognostic index for risk of progression of Kaposis Sarcoma
Tenofovir did not increase the incidence nephrotoxicity in limited numbers of HIV-positive patients using chemotherapy or HCV-coinfeced patients using ribavirin
Selected abstracts from Track A presentations at Toronto
Use of complementary alternative medicine that could interact with ARV treatment reported by 20% patients in the UK
Poor scientific or medical knowledge is a factor in increase in criminal charges for HIV transmission in the UK
Treatment access and community responses: online webcasts and debates
Antiretrovirals
Antiretroviral effect of foscarnet in patients with multiple drug resistance in late stage HIV disease
Treatment access
Patent oppositions filed on three essential drugs
Guidelines
WHO guidelines for ARV treatment in resource limited settings (2006)
On the web
AIDS issue of the British medical journal The Lancet online
TAG pipeline drugs report: July 2006
OSI/TAG report on civil society involvement in TB/HIV
Tuberculosis R&D Investments: A Preliminary Assessment
Resource for HIV-positive travellers: HIV/AIDS regulations
PDFs
Volume 7 Number 9 September 2006 PDF
HTB RSS
Current issues
October 2024
September 2024
August 2024
Back issues
Special report
HIV diagnoses in England jump by 51% in 2023: missing targets and highlighting disparities in access to care
6 October 2024
More from HTB
Conference reports
Conference shortcuts
Articles by subject
PDFs
Subscribe
HTB homepage
Home
i-Base homepage